2020
DOI: 10.1002/jbm.a.37125
|View full text |Cite
|
Sign up to set email alerts
|

An in vitro assessment of the response of THP‐1 macrophages to varying stiffness of a glycol‐chitosan hydrogel for vocal fold tissue engineering applications

Abstract: The physical properties of a biomaterial play an essential role in regulating immune and reparative activities within the host tissue. This study aimed to evaluate the immunological impact of material stiffness of a glycol‐chitosan hydrogel designed for vocal fold tissue engineering. Hydrogel stiffness was varied via the concentration of glyoxal cross‐linker applied. Hydrogel mechanical properties were characterized through atomic force microscopy and shear plate rheometry. Using a transwell setup, macrophages… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 83 publications
0
15
0
Order By: Relevance
“…All of the studies were published between January 2010 and March 2021. In general, ten studies aimed to develop new formulation of biomaterials [ 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 ]; three studies focused in improving or characterizing current biomaterials [ 46 , 47 , 48 ]; one study investigated the effect of the biomaterials toward inflammation [ 49 ]; three studies intended to improve fabrication methods in order to produce better biomaterials [ 36 , 46 , 50 ]. The biomaterials studied in the included articles were carbomer hydrogel, micronized dermal graft tissue, crosslinked HA, HA with gelatine hydrogel, CaHA, carboxymethylcellulose (CMC), bovine collagen, micronized alloderm (Cymetra) (Lifecell Corp, Branchburg, NJ, USA), HA gel, carboxylic and hydroxylic multi-walled functionalized carbon, unequal particle sized middle viscosity and low viscosity HA, Rofilan (Laborata es Filorga, Lisbonne, Paris, France),Radiesse (Merz, Franksville, WI, USA),Restylane (Galderma Laboratories, Fort Worth, TX, USA), dextran beads in HA microsphere (MP), polyethylene glycol-diamine (PEG) microparticles, gelatine methacrylate MP, HA methacrylate, semi-IPN MP, glycol chitosan hydrogel, pluronic F127 with collagen, HA with poly(ethylene glycol) diacrylate (PEGDA) crosslinkers, silk protein based in HA suspension, resilin-like-polypeptide hydrogel, PEG30 hydrogel and polydimethylsiloxane (PDMS) with polydopamine (PDA).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…All of the studies were published between January 2010 and March 2021. In general, ten studies aimed to develop new formulation of biomaterials [ 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 ]; three studies focused in improving or characterizing current biomaterials [ 46 , 47 , 48 ]; one study investigated the effect of the biomaterials toward inflammation [ 49 ]; three studies intended to improve fabrication methods in order to produce better biomaterials [ 36 , 46 , 50 ]. The biomaterials studied in the included articles were carbomer hydrogel, micronized dermal graft tissue, crosslinked HA, HA with gelatine hydrogel, CaHA, carboxymethylcellulose (CMC), bovine collagen, micronized alloderm (Cymetra) (Lifecell Corp, Branchburg, NJ, USA), HA gel, carboxylic and hydroxylic multi-walled functionalized carbon, unequal particle sized middle viscosity and low viscosity HA, Rofilan (Laborata es Filorga, Lisbonne, Paris, France),Radiesse (Merz, Franksville, WI, USA),Restylane (Galderma Laboratories, Fort Worth, TX, USA), dextran beads in HA microsphere (MP), polyethylene glycol-diamine (PEG) microparticles, gelatine methacrylate MP, HA methacrylate, semi-IPN MP, glycol chitosan hydrogel, pluronic F127 with collagen, HA with poly(ethylene glycol) diacrylate (PEGDA) crosslinkers, silk protein based in HA suspension, resilin-like-polypeptide hydrogel, PEG30 hydrogel and polydimethylsiloxane (PDMS) with polydopamine (PDA).…”
Section: Resultsmentioning
confidence: 99%
“…To further identify suitable biomaterials, in vitro studies must include evaluations to elucidate the cellular response when integrated with the biomaterials. In vitro outcomes measured in this review included cell adhesion [ 43 ], cell viability/compatibility [ 37 , 39 , 50 ], cell phenotyping [ 49 ] and production of cytokines [ 49 ]. Among the types of cell used were human vocal fold fibroblasts (HVFF), NIH/3T3 cells, macrophages, vocal fold fibroblasts (VFF), Hacat cells and mouse NIH-3T3 embryonic fibroblasts.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…utilized a mix of carbodiimide, neomycin trisulfate, and pentagalloyl glucose as a substitute for glutaraldehyde to crosslink porcine aortic valve leaflet ECM for enhanced biocompatibility and resistance to enzymatic degradation. [ 131 ] Glyoxal, another dialdehyde crosslinker similar to glutaraldehyde, [ 138,139 ] was believed to be less cytotoxic than glutaraldehyde. For example, Browe et al.…”
Section: Immunocompatibility Of Engineered Tissue or Organ‐based Implantsmentioning
confidence: 99%